0001140361-22-039689 | 10-Q | XBRL Viewer

Print Document View Excel Document

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2022	Oct. 31, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Document Transition Report	false
Entity File Number	001-12421
Entity Registrant Name	NU SKIN ENTERPRISES, INC.
Entity Central Index Key	0001021561
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-0565309
Entity Address, Address Line One	75 West Center Street
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84601
City Area Code	801
Local Phone Number	345-1000
Title of 12(b) Security	Class A Common Stock, $.001 par value
Trading Symbol	NUS
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		49,420,202

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 294,136	$ 339,593
Current investments	13,868	15,221
Accounts receivable, net	47,991	41,299
Inventories, net	327,481	399,931
Prepaid expenses and other	94,366	76,906
Total current assets	777,842	872,950
Property and equipment, net	433,367	453,674
Operating lease right-of-use assets	105,103	120,973
Goodwill	206,432	206,432
Other intangible assets, net	68,743	76,991
Other assets	171,685	175,460
Total assets	1,763,172	1,906,480
Current liabilities:
Accounts payable	41,620	49,993
Accrued expenses	281,418	372,201
Current portion of long-term debt	42,500	107,500
Total current liabilities	365,538	529,694
Operating lease liabilities	78,053	88,759
Long-term debt	382,323	268,781
Other liabilities	95,324	106,474
Total liabilities	921,238	993,708
Commitments and contingencies (Notes 5 and 11)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	609,886	601,703
Treasury stock, at cost - 40.9 million and 40.7 million shares	(1,559,967)	(1,526,860)
Accumulated other comprehensive loss	(109,385)	(73,896)
Retained earnings	1,901,309	1,911,734
Total stockholders' equity	841,934	912,772
Total liabilities and stockholders' equity	$ 1,763,172	$ 1,906,480

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares shares in Millions	Sep. 30, 2022	Dec. 31, 2021
Stockholders' equity:
Common stock, shares authorized (in shares)	500.0	500.0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	40.9	40.7

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Consolidated Statements of Income [Abstract]
Revenue	$ 537,805	$ 641,152	$ 1,703,319	$ 2,022,233
Cost of sales	173,500	158,907	483,099	501,448
Gross profit	364,305	482,245	1,220,220	1,520,785
Operating expenses:
Selling expenses	216,478	260,333	678,603	816,887
General and administrative expenses	137,987	156,528	428,105	490,225
Restructuring and impairment expenses	30,124	0	30,124	0
Total operating expenses	384,589	416,861	1,136,832	1,307,112
Operating income (loss)	(20,284)	65,384	83,388	213,673
Other income (expense), net	(8,680)	2,781	(18,773)	351
Income (loss) before provision for income taxes	(28,964)	68,165	64,615	214,024
Provision (benefit) for income taxes	(3,574)	18,436	17,052	57,527
Net income (loss)	$ (25,390)	$ 49,729	$ 47,563	$ 156,497
Net income (loss) per share (Note 6):
Basic (in dollars per share)	$ (0.51)	$ 0.99	$ 0.95	$ 3.11
Diluted (in dollars per share)	$ (0.51)	$ 0.97	$ 0.94	$ 3.03
Weighted-average common shares outstanding:
Basic (in shares)	50,199	50,098	50,187	50,304
Diluted (in shares)	50,199	51,260	50,822	51,629

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Consolidated Statements of Comprehensive Income [Abstract]
Net income (loss)	$ (25,390)	$ 49,729	$ 47,563	$ 156,497
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustment, net of taxes of $(10) and $(1) for the three months ended September 30, 2022 and 2021, respectively, and $19 and $1 for the nine months ended September 30, 2022 and 2021, respectively	(22,502)	(7,165)	(46,914)	(13,431)
Net unrealized gains/(losses) on cash flow hedges, net of taxes of $(1,262) and $(7) for the three months ended September 30, 2022 and 2021, respectively and $(3,441) and $(678) for the nine months ended September 30, 2022 and 2021, respectively	4,570	25	12,462	2,455
Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedges, net of taxes of $225 and $(10) for the three months ended September 30, 2022 and 2021, respectively and $286 and $(24) for the nine months ended September 30, 2022 and 2021, respectively	(815)	35	(1,037)	86
Other comprehensive (loss) income, net of tax	(18,747)	(7,105)	(35,489)	(10,890)
Comprehensive income (loss)	$ (44,137)	$ 42,624	$ 12,074	$ 145,607

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustment, tax	$ (10)	$ (1)	$ 19	$ 1
Net unrealized gains/(losses) on foreign currency cash flow hedges, tax	(1,262)	(7)	(3,441)	(678)
Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedges, tax	$ 225	$ (10)	$ 286	$ (24)

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member] Class A [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total
Balance at beginning of period at Dec. 31, 2020	$ 91	$ 579,801	$ (1,461,593)	$ (64,768)	$ 1,840,740	$ 894,271
Stockholders' Equity [Roll Forward]
Net income (loss)	0	0	0	0	156,497	156,497
Other comprehensive income (loss), net of tax	0	0	0	(10,890)	0	(10,890)
Repurchase of Class A common stock (Note 6)	0	0	(70,415)	0	0	(70,415)
Exercise of employee stock options/vesting of stock awards	0	(5,599)	13,473	0	0	7,874
Stock-based compensation	0	16,476	0	0	0	16,476
Cash dividends	0	0	0	0	(57,336)	(57,336)
Balance at end of period at Sep. 30, 2021	91	590,678	(1,518,535)	(75,658)	1,939,901	936,477
Balance at beginning of period at Jun. 30, 2021	91	586,976	(1,509,867)	(68,553)	1,909,179	917,826
Stockholders' Equity [Roll Forward]
Net income (loss)	0	0	0	0	49,729	49,729
Other comprehensive income (loss), net of tax	0	0	0	(7,105)	0	(7,105)
Repurchase of Class A common stock (Note 6)	0	0	(10,005)	0	0	(10,005)
Exercise of employee stock options/vesting of stock awards	0	609	1,337	0	0	1,946
Stock-based compensation	0	3,093	0	0	0	3,093
Cash dividends	0	0	0	0	(19,007)	(19,007)
Balance at end of period at Sep. 30, 2021	91	590,678	(1,518,535)	(75,658)	1,939,901	936,477
Balance at beginning of period at Dec. 31, 2021	91	601,703	(1,526,860)	(73,896)	1,911,734	912,772
Stockholders' Equity [Roll Forward]
Net income (loss)	0	0	0	0	47,563	47,563
Other comprehensive income (loss), net of tax	0	0	0	(35,489)	0	(35,489)
Repurchase of Class A common stock (Note 6)	0	0	(60,038)	0	0	(60,038)
Exercise of employee stock options/vesting of stock awards	0	(1,137)	26,931	0	0	25,794
Stock-based compensation	0	9,320	0	0	0	9,320
Cash dividends	0	0	0	0	(57,988)	(57,988)
Balance at end of period at Sep. 30, 2022	91	609,886	(1,559,967)	(109,385)	1,901,309	841,934
Balance at beginning of period at Jun. 30, 2022	91	606,349	(1,520,769)	(90,638)	1,946,002	941,035
Stockholders' Equity [Roll Forward]
Net income (loss)	0	0	0	0	(25,390)	(25,390)
Other comprehensive income (loss), net of tax	0	0	0	(18,747)	0	(18,747)
Repurchase of Class A common stock (Note 6)	0	0	(40,028)	0	0	(40,028)
Exercise of employee stock options/vesting of stock awards	0	366	830	0	0	1,196
Stock-based compensation	0	3,171	0	0	0	3,171
Cash dividends	0	0	0	0	(19,303)	(19,303)
Balance at end of period at Sep. 30, 2022	$ 91	$ 609,886	$ (1,559,967)	$ (109,385)	$ 1,901,309	$ 841,934

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 23
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 105
-SubTopic 10
-Section 65
-Paragraph 6
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 105
-SubTopic 10
-Section 65
-Paragraph 6
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(3)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 5
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (d)(2)
-URI https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 848
-SubTopic 10
-Section 65
-Paragraph 2
-Subparagraph (a)(3)(iii)(03)
-URI https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 17
-URI https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (d)(3)
-URI https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333

Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900

Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (f)(1)
-URI https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333

+ Details

Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical) - shares shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stockholders' Equity [Roll Forward]
Exercise of employee stock options (in shares)	0.1	0.1	1.2	0.6

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income	$ 47,563	$ 156,497
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization	53,935	57,858
Non-cash lease expense	33,250	40,703
Stock-based compensation	9,320	16,476
Foreign currency losses	7,077	5,501
Loss on disposal of assets	568	13,210
Deferred taxes	2,483	3,846
Impairment of fixed assets and other intangibles	9,916	0
Unrealized gain on equity investments	0	(18,077)
Changes in operating assets and liabilities:
Accounts receivable, net	(15,523)	8,377
Inventories, net	48,422	(109,371)
Prepaid expenses and other	(6,801)	(29,311)
Other assets	8,030	(18,438)
Accounts payable	(1,224)	(11,182)
Accrued expenses	(95,928)	(89,993)
Other liabilities	(18,551)	5,977
Net cash provided by operating activities	82,537	32,073
Cash flows from investing activities:
Purchases of property and equipment	(45,274)	(50,384)
Proceeds on investment sales	5,535	11,171
Purchases of investments	(13,955)	(14,973)
Acquisitions, net of cash acquired	0	(18,963)
Net cash used in investing activities	(53,694)	(73,149)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	25,794	7,874
Payment of cash dividends	(57,988)	(57,336)
Repurchases of shares of common stock	(60,038)	(70,415)
Finance lease principal payments	(1,401)	(1,409)
Payment of debt issuance costs	(5,077)	0
Payments of debt	(410,000)	(77,500)
Proceeds from debt	460,000	130,000
Net cash used in financing activities	(48,710)	(68,786)
Effect of exchange rate changes on cash	(25,590)	(10,409)
Net increase (decrease) in cash and cash equivalents	(45,457)	(120,271)
Cash and cash equivalents, beginning of period	339,593	402,683
Cash and cash equivalents, end of period	$ 294,136	$ 282,412

The Company

9 Months Ended

Sep. 30, 2022

The Company [Abstract]

The Company

1.	The Company

Nu Skin Enterprises, Inc. (the “Company”) is a holding company, with Nu Skin, being the primary operating unit. Nu Skin develops and distributes premium-quality, innovative beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands and a small number of other products and services. The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments—Americas, which includes Canada, Latin America and the United States; Mainland China; Southeast Asia/Pacific, which includes Australia, Indonesia, Malaysia, New Zealand, the Philippines, Singapore, Thailand and Vietnam; South Korea; Japan; Europe, Middle East and Africa (“EMEA”), which includes markets in Europe as well as Israel and South Africa; and Hong Kong/Taiwan, which also includes Macau—and two Rhyz Investments segments—Manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz other, which includes other investments by its Rhyz strategic investment arm (the Company’s subsidiaries operating within each segment are collectively referred to as the “Subsidiaries”).

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2022

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2.	Summary of Significant Accounting Policies

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information as of September 30, 2022, and for the three-and nine-month periods ended September 30, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December 31, 2021 has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current presentation. The Company reclassified $4.6 million and $9.5 million of events and other miscellaneous selling costs from the general and administration expenses line to the selling expenses line on the consolidated statement of income for the three- and nine-month periods ended September 30, 2021, respectively. The Company believes these costs are better reflected in selling expenses. The reclassification had no impact on operating income for the three- and nine-month periods ended September 30, 2021.

Accounting Pronouncements

In March 2020, the Financial Accounting Standards Board (“FASB”) issued, ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance for a limited time to ease the potential burden in accounting for the effects of reference rate reform on financial reporting. The guidance provides optional expedients and exceptions for applying US GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU 2020-04 applies only to contracts and hedging relationships that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued due to reference rate reform. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. The amendments in ASU 2020-04 are elective and are effective upon issuance for all entities. The Company had previously elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. In the second quarter of 2022, the Company elected the hedge accounting expedient that allows an update to the hedged risk in active hedging relationships without de-designation as the Company’s debt transitioned to Secured Overnight Financing Rate (“SOFR”). Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.

Inventory

Inventories consist of the following (U.S. dollars in thousands):

	September 30, 2022		December 31, 2021
Raw materials	$	141,823	$	179,891
Finished goods		185,658		220,040
Total Inventory, net	$	327,481	$	399,931

Revenue Recognition

Contract Liabilities – Customer Loyalty Programs

Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products.

The balance of deferred revenue related to contract liabilities as of September 30, 2022 and December 31, 2021 was $17.7 million and $22.0 million, respectively. The contract liabilities impact to revenue for the three-month periods ended September 30, 2022, and 2021 was an increase of $0.7 million and a decrease of $0.7 million, respectively. The impact to revenue for the nine-month periods ended September 30, 2022, and 2021 was an increase of $4.3 million and a decrease of $6.3 million, respectively.

Goodwill

9 Months Ended

Sep. 30, 2022

Goodwill [Abstract]

Goodwill

The Company’s reporting units for goodwill are its operating segments, which are also its reportable segments.

The following table presents goodwill allocated to the Company’s reportable segments for the periods ended September 30, 2022 and December 31, 2021 (U.S. dollars in thousands):

	September 30, 2022		December 31, 2021
Nu Skin
Americas	$	9,449	$	9,449
Mainland China		32,179		32,179
Southeast Asia/Pacific		18,537		18,537
South Korea		29,261		29,261
Japan		16,019		16,019
EMEA		2,875		2,875
Hong Kong/Taiwan		6,634		6,634
Rhyz Investments
Manufacturing		78,875		78,875
Rhyz Other		12,603		12,603
Total	$	206,432	$	206,432

Debt

9 Months Ended

Sep. 30, 2022

Debt [Abstract]

Debt

2018 Credit Agreement

On April 18, 2018, the Company entered into a Credit Agreement (the “2018 Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent. The 2018 Credit Agreement provided for a $400 million term loan facility and a $350 million revolving credit facility, each with a term of five years. Both facilities bore interest at the LIBOR, plus a margin based on the consolidated leverage ratio. The term loan facility amortized in quarterly installments in amounts resulting in an annual amortization of 5.0% during the first and second years, 7.5% during the third and fourth years and 10.0% during the fifth year after the closing date of the 2018 Credit Agreement, with the remainder payable at final maturity. The 2018 Credit Agreement required the Company to maintain a consolidated leverage ratio not exceeding 2.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00.

Credit Agreement

On June 14, 2022, the Company entered into an Amended and Restated Credit Agreement (the “Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent, which amended and restated the 2018 Credit Agreement. The Credit Agreement provides for a $400 million term loan facility and a $500 million revolving credit facility, each with a term of five years. Both facilities bear interest at the SOFR, plus a margin based on the Company’s consolidated leverage ratio. Commitment fees payable under the Credit Agreement are also based on the consolidated leverage ratio as defined in the Credit Agreement and range from 0.175% to 0.30% on the unused portion of the total lender commitments then in effect. The term loan facility amortizes in quarterly installments in amounts resulting in an annual amortization of 2.5% during the first year and 5.0% during the second, third, fourth and fifth years after the closing date of the Credit Agreement, with the remainder payable at final maturity. The Credit Agreement is guaranteed by certain of the Company’s domestic subsidiaries and collateralized by assets of such subsidiaries, including a pledge of 65% of the capital stock of certain foreign subsidiaries. The Credit Agreement requires the Company to maintain a consolidated leverage ratio not exceeding 2.75 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. As of September 30, 2022, the Company was in compliance with all covenants under the Credit Agreement.

The following table summarizes the Company’s debt facilities as of September 30, 2022 and December 31, 2021:

Facility or Arrangement	Original Principal Amount	Balance as of September 30, 2022 ⁽¹⁾⁽²⁾	Balance as of December 31, 2021⁽¹⁾⁽²⁾	Interest Rate	Repayment Terms
2018 Credit Agreement term loan facility	$400.0 million	—	$307.5 million	Variable 30 day: 2.80%	Principal amount was paid in full during June 2022.

2018 Credit Agreement revolving credit facility		—	$70.0 million	Variable 30 day: 2.72%	Principal amount was paid in full during June 2022 and credit line was closed.

Credit Agreement term loan facility	$400.0 million	$397.5 million	—	Variable 30 day: 4.88%	21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term.

Credit Agreement revolving credit facility		$30.0 million	—	Variable 30 day: 4.88%	Revolving line of credit expires June 14, 2027.

(1)	As of September 30, 2022 and December 31, 2021, the current portion of the Company’s debt (i.e., becoming due in the next 12 months) included $12.5 million and $37.5 million, respectively, of the balance of its term loan under the Credit Agreement and 2018 Credit Agreement.

(2)	The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.7 million and $1.2 million as of September 30, 2022 and December 31, 2021, respectively, related to the Credit Agreement and 2018 Credit Agreement, which are not reflected in this table.

Leases

9 Months Ended

Sep. 30, 2022

Leases [Abstract]

Leases

As of September 30, 2022, the weighted average remaining lease term was 8.4 and 3.0 years for operating and finance leases, respectively. As of September 30, 2022, the weighted average discount rate was 3.5% and 3.8% for operating and finance leases, respectively.

The components of lease expense were as follows (U.S. dollars in thousands):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2022		2021			2022		2021
Operating lease expense
Operating lease cost	$	9,479	$	12,193		$	30,179	$	37,408
Variable lease cost		1,572		1,121			4,223		4,145
Short-term lease cost		84		13			181		590
Sublease income		—		(1,352	)		—		(5,164	)
Finance lease expense
Amortization of right-of-use assets		530		594			1,632		1,811
Interest on lease liabilities		53		77			178		248
Total lease expense	$	11,718	$	12,646		$	36,393	$	39,038

Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands):

	Nine Months Ended September 30,
	2022		2021
Operating cash outflow from operating leases	$	28,880	$	40,072
Operating cash outflow from finance leases	$	170	$	250
Financing cash outflow from finance leases	$	1,401	$	1,409
Right-of-use assets obtained in exchange for operating lease obligations	$	28,785	$	19,120
Right-of-use assets obtained in exchange for finance lease obligations	$	203	$	59

Maturities of lease liabilities were as follows (U.S. dollars in thousands):

Year Ending December 31	Operating Leases		Finance Leases
2022	$	9,453	$	505
2023		26,680		1,884
2024		19,671		1,688
2025		13,775		1,209
2026		8,127		264
Thereafter		46,139		4
Total		123,845		5,554
Less: Finance charges		16,736		319
Total principal liability	$	107,109	$	5,235

The Company has additional lease liabilities of $0.1 million which have not yet commenced as of September 30, 2022, and as such, have not been recognized on the consolidated balance sheets.

Capital Stock

9 Months Ended

Sep. 30, 2022

Capital Stock [Abstract]

Capital Stock

6.	Capital Stock

Net income per share

Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended September 30, 2022 and 2021, stock options of 0.5 million and 0.1 million, respectively, and for the nine-month periods ended September 30, 2022 and 2021, stock options of 0.1 million and 0.1 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive.

Dividends

In February, May and August 2022, the Company’s board of directors declared quarterly cash dividends of $0.385 per share. These quarterly cash dividends of $19.3 million, $19.4 million and $19.3 million were paid on March 9, 2022, June 8, 2022 and September 7, 2022, respectively, to stockholders of record on February 28, 2022, May 27, 2022 and August 26, 2022, respectively. In October 2022, the Company’s board of directors declared a quarterly cash dividend of $0.385 per share to be paid on December 7, 2022 to stockholders of record on November 25, 2022.

Repurchase of common stock

During the three-month periods ended September 30, 2022 and 2021, the Company repurchased 1.0 million and 0.2 million shares of its Class A common stock under its stock repurchase plan for $40.0 million and $10.0 million, respectively. During the nine-month periods ended September 30, 2022 and 2021, the Company repurchased 1.4 million shares and 1.4 million shares of its Class A common stock under its stock repurchase plan for $60.0 million and $70.4 million, respectively. As of September 30, 2022, $185.4 million was available for repurchases under the Company’s stock repurchase plan.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

Fair Value and Equity Investments

9 Months Ended

Sep. 30, 2022

Fair Value and Equity Investments [Abstract]

Fair Value and Equity Investments

7.	Fair Value and Equity Investments

Fair Value

The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximates fair values due to the short-term nature of these instruments. The carrying value of debt approximates fair value due to the variable 30-day interest rate. Fair value estimates are made at a specific point in time, based on relevant market information.

The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy:

■

Level 1 – quoted prices in active markets for identical assets or liabilities;

■

Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

■

Level 3 – unobservable inputs based on the Company’s own assumptions.

Accounting standards permit companies, at their option, to measure certain financial instruments and other eligible items at fair value. The Company has elected not to apply the fair value option to existing eligible items beyond what is required by US GAAP.

The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands):

	Fair Value at September 30, 2022
	Level 1		Level 2		Level 3			Total
Financial assets (liabilities):
Cash equivalents and current investments	$	68,552	$	—	$	—		$	68,552
Derivative financial instruments asset		—		21,168		—			21,168
Life insurance contracts		—		—		38,302			38,302
Contingent consideration		—		—		(8,372	)		(8,372	)
Total	$	68,552	$	21,168	$	29,930		$	119,650

	Fair Value at December 31, 2021
	Level 1		Level 2		Level 3			Total
Financial assets (liabilities):
Cash equivalents and current investments	$	66,477	$	—	$	—		$	66,477
Derivative financial instruments asset		—		6,590		—			6,590
Life insurance contracts		—		—		49,851			49,851
Contingent consideration		—		—		(10,341	)		(10,341	)
Total	$	66,477	$	6,590	$	39,510		$	112,577

The following table provides a summary of changes in fair value of the Company’s Level 3 life insurance contracts (U.S. dollars in thousands):

	2022			2021
Beginning balance at January 1	$	49,851		$	45,453
Actual return on plan assets		(11,549	)		3,172
Purchases and issuances		—			7,016
Sales and settlements		—			(7,016	)
Transfers into Level 3		—			—
Ending balance at September 30	$	38,302		$	48,625

Life insurance contracts: Accounting Standards Codification (“ASC”) 820 preserves practicability exceptions to fair value measurements provided by other applicable provisions of U.S. GAAP. The guidance in ASC 715-30-35-60 allows a reporting entity, as a practical expedient, to use cash surrender value or conversion value as an expedient for fair value when it is present. Accordingly, the Company determines the fair value of its life insurance contracts as the cash-surrender value of life insurance policies held in its Rabbi Trust.

The following table provides a summary of changes in fair value of the Company’s Level 3 contingent consideration (U.S. dollars in thousands):

	2022			2021
Beginning balance at January 1	$	(10,341	)	$	(3,125	)
Additions from acquisitions		—			(8,702	)
Changes in fair value of contingent consideration		1,969			(305	)
Ending balance at September 30	$	(8,372	)	$	(12,132	)

Contingent consideration: Contingent consideration represents the obligations incurred in connection with acquisitions. The estimate of fair value of the contingent consideration obligations requires subjective assumptions to be made regarding the future business results, discount rates, discount periods and probabilities assigned to various potential business result scenarios and was determined using probability assessments with respect to the likelihood of reaching various targets or of achieving certain milestones. The fair value measurement is based on significant inputs unobservable in the market and thus represents a Level 3 measurement. Changes in current expectations of progress could change the probability of achieving the targets within the measurement periods and result in an increase or decrease in the fair value of the contingent consideration obligation.

Equity Investments

The Company maintains equity investments in companies which are accounted for under the measurement alternative described in ASC 321-10-35-2 for equity securities that lack readily determinable fair values. The carrying amount of equity securities held by the Company without readily determinable fair values was $28.1 million at each of September 30, 2022 and December 31, 2021. During the three months ended September 30, 2021, the Company recognized $18.1 million upward fair value adjustments, based on the valuation of additional equity issued by the investee which was deemed to be an observable transaction of a similar investment under ASC 321. The third quarter of 2021 gain was recorded within Other income (expense), net on the Consolidated Statement of Income. The upward fair value adjustment represents a nonrecurring fair value measurement based on observable price changes and is classified as a Level 3 fair value measurement.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Income Taxes

9 Months Ended

Sep. 30, 2022

Income Taxes [Abstract]

Income Taxes

8.	Income Taxes

Provision for income taxes for the three- and nine-month periods ended September 30, 2022 was $(3.6) million and $17.1 million, compared to $18.4 million and $57.5 million for the prior-year periods. The effective tax rates for the three- and nine-month periods ended September 30, 2022, were 12.3% and 26.4% of pre-tax income compared to 27.0% and 26.9% in the prior-year periods.

The Company accounts for income taxes in accordance with ASC Topic 740 “Income Taxes.” These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise’s activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. The Company had net deferred tax assets of $22.2 million and $24.1 million as of September 30, 2022 and December 31, 2021, respectively.

The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter. For all foreign earnings, the Company accrues the applicable foreign income taxes. For the earnings that have been indefinitely reinvested, the Company does not accrue foreign withholding taxes. Undistributed earnings that the Company has indefinitely reinvested, for which no foreign withholding taxes have been provided, aggregate to $60.0 million as of December 31, 2021. If the amount designated as indefinitely reinvested as of December 31, 2021 was repatriated to the United States, the amount of incremental taxes would be approximately $6.0 million. The Company intends to utilize the indefinitely reinvested offshore earnings to fund foreign investments, specifically capital expenditures.

The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process (“CAP”). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. As of December 31, 2021, tax years through 2020 have been audited and are effectively closed to further examination. For tax years 2021 and 2022, the Company is in the Bridge phase of the CAP program, pursuant to which the IRS will not accept disclosures, will not conduct reviews and will not provide letters of assurance for the Bridge years. There are limited circumstances under which tax years in the Bridge phase will be opened for examination. The Company may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2018. In major foreign jurisdictions, the Company is generally no longer subject to income tax examinations for years before 2016. However, statutes of limitations in certain countries may be as long as ten years. The Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable. The Company’s unrecognized tax benefits relate to multiple jurisdictions. Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitations, it is reasonably possible that the Company’s gross unrecognized tax benefits, net of foreign currency adjustments, may increase in the next 12 months by approximately $1.0 to $2.0 million.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Derivatives and Hedging Activities

9 Months Ended

Sep. 30, 2022

Derivatives and Hedging Activities [Abstract]

Derivatives and Hedging Activities

9.	Derivatives and Hedging Activities

Risk Management Objective of Using Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During 2022, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.

For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income and subsequently reclassified into interest expense/income in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense/income as interest payments are made/received on the Company’s variable-rate debt. During the next twelve months, the Company estimates that an additional $8.2 million will be reclassified as a reduction to interest expense.

As of September 30, 2022 and December 31, 2021, the Company had four outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk with a total notional amount of $200 million.

Fair Values of Derivative Instruments on the Balance Sheet

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet:

		Fair Values of Derivative Instruments
Derivatives in Cash flow Hedging Relationships:	Balance Sheet Location	September 30, 2022		December 31, 2021
Interest Rate Swap - Asset	Prepaid expenses and other	$	8,178	$	557
Interest Rate Swap - Asset	Other assets	$	12,990	$	6,033

Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income

The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income.

	Amount of Gain (Loss) Recognized in OCI on Derivatives
	Three Months Ended				Nine Months Ended
Derivatives in Cash flow	September 30,				September 30,
Hedging Relationships:	2022		2021		2022		2021
Interest Rate Swaps	$	5,832	$	32	$	15,903	$	3,133

		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income
		Three Months Ended					Nine Months Ended
Derivatives in Cash flow	Income Statement	September 30,					September 30,
Hedging Relationships:	Location	2022		2021			2022		2021
Interest Rate Swaps	Other income (expense), net	$	1,040	$	(45	)	$	1,323	$	(110	)

Segment Information

9 Months Ended

Sep. 30, 2022

Segment Information [Abstract]

Segment Information

10.	Segment Information

The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments—Americas, Mainland China, Southeast Asia/Pacific, South Korea, Japan, EMEA, and Hong Kong/Taiwan—and two Rhyz Investments segments—Manufacturing and Rhyz other. The Nu Skin other category includes miscellaneous corporate revenue and related adjustments. The Rhyz other segment includes other investments by our Rhyz strategic investment arm. These segments reflect the way the chief operating decision maker evaluates the Company’s business performance and allocates resources. Reported revenue includes only the revenue generated by sales to external customers.

Profitability by segment as determined under US GAAP is driven primarily by the Company’s transfer pricing policies. Segment contribution, which is the Company’s segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company’s executive and administrative offices, information technology, research and development, and marketing and supply chain functions not recorded at the segment level.

Prior year segment information has been recast to reflect the move of the Pacific components from the “America/Pacific” operating segment to the “Southeast Asia/Pacific” operating segment to comply with current segment presentation. Prior year segment information has been recast to reflect the fourth quarter 2021 exit of the Grow Tech segment, which has been recast to Corporate and other expenses. Consolidated financial information is not affected.

The accounting policies of the segments are the same as those described in Note 2 – Summary of Significant Accounting Policies. The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations.

Summarized financial information for the Company’s reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company’s internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment.

Revenue by Segment

	Three Months Ended September 30,				Nine Months Ended September 30,
(U.S. dollars in thousands)	2022		2021		2022		2021

Nu Skin
Americas	$	131,591	$	131,482	$	379,616	$	403,755
Mainland China		75,151		134,291		286,454		438,066
Southeast Asia/Pacific		83,502		79,081		267,805		246,338
South Korea		67,237		91,989		208,678		261,724
Japan		53,276		65,117		171,019		203,001
EMEA		45,099		55,839		148,938		215,134
Hong Kong/Taiwan		39,587		39,921		117,408		114,795
Nu Skin other		496		1,672		2,434		3,497
Total Nu Skin		495,939		599,392		1,582,352		1,886,310
Rhyz Investments
Manufacturing ⁽¹⁾		41,328		41,635		119,898		135,760
Rhyz other		538		125		1,069		163
Total Rhyz Investments		41,866		41,760		120,967		135,923
Total	$	537,805	$	641,152	$	1,703,319	$	2,022,233

(1)

The Manufacturing segment had $17.5 million and $27.4 million of intersegment revenue for the three months ended September 30, 2022 and 2021, respectively, and $48.9 million and $68.0 million for the nine months ended September 30, 2022 and 2021, respectively. Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above.

Segment Contribution

	Three Months Ended September 30,						Nine Months Ended September 30,
(U.S. dollars in thousands)	2022			2021			2022			2021
Nu Skin
Americas	$	23,016		$	25,752		$	78,165		$	83,495
Mainland China		12,933			30,677			54,873			121,596
Southeast Asia/Pacific		20,719			19,020			68,492			59,881
South Korea		20,455			28,984			63,776			84,401
Japan		13,103			16,267			41,867			50,709
EMEA		3,379			6,693			13,377			29,270
Hong Kong/Taiwan		8,425			8,940			26,276			24,848
Nu Skin contribution		102,030			136,333			346,826			454,200
Rhyz Investments
Manufacturing		1,755			3,059			6,235			15,649
Rhyz other		(1,724	)		(659	)		(4,069	)		(1,178	)
Rhyz Investments contribution		31			2,400			2,166			14,471
Total segment contribution		102,061			138,733			348,992			468,671
Corporate and other		(122,345	)		(73,349	)		(265,604	)		(254,998	)
Operating income		(20,284	)		65,384			83,388			213,673
Other income (expense)		(8,680	)		2,781			(18,773	)		351
Income before provision for income taxes	$	(28,964	)	$	68,165		$	64,615		$	214,024

Depreciation and Amortization

	Three Months Ended September 30,				Nine Months Ended September 30,
(U.S. dollars in thousands)	2022		2021		2022		2021
Nu Skin
Americas	$	89	$	190	$	480	$	656
Mainland China		3,528		3,253		9,088		9,868
Southeast Asia/Pacific		382		359		1,144		1,096
South Korea		377		805		1,137		2,768
Japan		148		220		670		699
EMEA		125		281		599		850
Hong Kong/Taiwan		743		1,004		2,152		2,794
Total Nu Skin		5,392		6,112		15,270		18,731
Rhyz Investments
Manufacturing		3,161		3,069		9,773		8,644
Rhyz other		592		592		1,776		987
Total Rhyz Investments		3,753		3,661		11,549		9,631
Corporate and other		9,025		10,160		27,116		29,496
Total	$	18,170	$	19,933	$	53,935	$	57,858

Capital Expenditures

	Three Months Ended September 30,				Nine Months Ended September 30,
(U.S. dollars in thousands)	2022		2021		2022		2021
Nu Skin
Americas	$	23	$	95	$	152	$	294
Mainland China		2,946		3,237		9,066		15,170
Southeast Asia/Pacific		19		92		143		1,015
South Korea		35		—		613		508
Japan		16		3		200		94
EMEA		183		391		961		821
Hong Kong/Taiwan		587		110		1,386		222
Total Nu Skin		3,809		3,928		12,521		18,124
Rhyz Investments
Manufacturing		1,923		2,604		4,353		11,604
Rhyz other		—		—		—		—
Total Rhyz Investments		1,923		2,604		4,353		11,604
Corporate and other		19,723		7,003		28,400		20,656
Total	$	25,455	$	13,535	$	45,274	$	50,384

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

+ Details

Commitments and Contingencies

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies [Abstract]

Commitments and Contingencies

11.	Commitments and Contingencies

The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company’s direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company’s sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company’s operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. No assurance can be given that the Company’s compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company’s financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation, investigations and other proceedings involving various matters. Management believes that the ultimate liability arising from such claims and contingencies, if any, is not likely to have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows.

The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company’s reserves, which would impact its reported financial results.

Acquisitions

9 Months Ended

Sep. 30, 2022

Acquisitions [Abstract]

Acquisitions

12.	Acquisitions

In April 2021, the Company acquired 100% ownership in MyFavoriteThings, Inc. (“Mavely”), making Mavely a wholly owned subsidiary of the Company. The acquisition enables the Company to continue to expand its digital tools. The purchase price for Mavely was $16.8 million, net of cash acquired of $0.4 million and $0.9 million to be paid within six months, all payable in cash. In addition, there is potential for an incremental $24.0 million in contingent consideration, which becomes payable if certain revenue and profitability targets are reached in 2021, 2022 and 2023. The fair value of the contingent consideration recorded on the acquisition date was $8.7 million. The Company allocated the gross purchase price of $29.4 million to the assets acquired and liabilities assumed at estimated fair values. The estimated fair value of assets acquired included $16.4 million of intangible assets, $0.4 million of cash, $0.1 million of accounts receivable, and also resulted in a deferred tax liability of $3.5 million. The excess purchase price over the aggregate fair value of assets acquired less liabilities assumed of $12.6 million was recorded as goodwill. The goodwill recognized is attributable primarily to expected synergies. None of the goodwill is expected to be deductible for income tax purposes. The intangible assets acquired were comprised of $2.0 million for customer relationships, $11.3 million for technology, $2.8 million for trademarks and $0.3 million for other intangibles. The intangibles were assigned useful lives of 8 years for the technology and tradename, approximately 4 years for the customer relationships and 3 years for the other intangibles. All the goodwill was assigned to our Rhyz other segment. The allocation of the fair value of assets acquired and liabilities assumed for the acquisition was finalized during the three months ended September 30, 2021.

Restructuring

9 Months Ended

Sep. 30, 2022

Restructuring [Abstract]

Restructuring

13.	Restructuring

In the fourth quarter of 2021, the Company determined to exit the Grow Tech segment, to better align its resources on key strategic initiatives to achieve the future growth objectives and priorities of the core Nu Skin business. The Grow Tech segment was pursuing the commercialization of controlled-environment agriculture for use in the agriculture feed industry. This segment had been operating as part of the Company’s Rhyz strategic investment arm. As a result of the restructuring program, the Company recorded a non-cash charge of $38.5 million in 2021, including $9.2 million for impairment of goodwill, $9.0 million for impairment of intangibles, $13.7 million of fixed asset impairments and $6.6 million for inventory write-off, and $20.0 million of cash charges, including $6.5 million for employee severance and $13.5 million for other related cash charges with our restructuring. As of December 31, 2021, the $20.0 million liability related to cash charges was recorded within Accrued expenses. During the first quarter of 2022, the Company made cash payments of $11.6 million, leaving an ending restructuring accrual of $8.3 million as of March 31, 2022. During the second quarter of 2022, the Company made cash payments of $8.0 million, leaving an ending restructuring accrual of $0.3 million as of June 30, 2022. During the third quarter of 2022, the Company made cash payments of $0.3 million, leaving no restructuring accrual as of September 30, 2022. The restructuring charges were recorded in the previous Grow Tech segment, which in the current year has been recast to Corporate and Other.

In the third quarter of 2022, the Company adopted a strategic plan to focus resources on the Company’s strategic priorities and optimize future growth and profitability. The global program includes workforce reductions and footprint optimization. The Company estimates total charges under the program will approximate $35–$45 million, with $30–$35 million in cash charges of severance and lease termination cost and $9.9 million of non-cash charges of impairment of fixed assets and other intangibles related to the footprint optimization. The Company expects to substantially complete the program during the first half of 2023. During the third quarter of 2022, the Company incurred charges to be settled in cash of $17.2 million in severance charges, $2.1 million in lease termination cost, and $0.9 million in other associated cost, and non-cash charges of $8.2 million in fixed asset impairments and $1.7 million in impairment of other intangibles. During the third quarter of 2022, the Company made cash payments of $7.9 million related to this global program, leaving an ending restructuring accrual of $12.3 million.

Restructuring expense by segment

(U.S. dollars in thousands)	Three Months Ended September 30,2022

Nu Skin
Americas	$	1,723
Mainland China		11,484
Southeast Asia/Pacific		663
South Korea		54
Japan		—
EMEA		894
Hong Kong/Taiwan		747
Total Nu Skin		15,565
Rhyz Investments
Manufacturing		—
Rhyz other		—
Total Rhyz Investments		—
Corporate and other		14,559
Total	$	30,124

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2022

Summary of Significant Accounting Policies [Abstract]

Basis of Accounting

Consolidation

The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Reclassifications

Accounting Pronouncements

Inventory

Inventories consist of the following (U.S. dollars in thousands):

	September 30, 2022		December 31, 2021
Raw materials	$	141,823	$	179,891
Finished goods		185,658		220,040
Total Inventory, net	$	327,481	$	399,931

Revenue Recognition

Contract Liabilities – Customer Loyalty Programs

- Definition

Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.

+ References + Details

- Definition

Disclosure of accounting policy for revenue from contract with customer.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 17
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 20
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 20
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 20
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 19
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 20
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045

+ Details

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2022

Summary of Significant Accounting Policies [Abstract]

Inventories

Inventories consist of the following (U.S. dollars in thousands):

	September 30, 2022		December 31, 2021
Raw materials	$	141,823	$	179,891
Finished goods		185,658		220,040
Total Inventory, net	$	327,481	$	399,931

Goodwill (Tables)

9 Months Ended

Sep. 30, 2022

Goodwill [Abstract]

Goodwill

The following table presents goodwill allocated to the Company’s reportable segments for the periods ended September 30, 2022 and December 31, 2021 (U.S. dollars in thousands):

	September 30, 2022		December 31, 2021
Nu Skin
Americas	$	9,449	$	9,449
Mainland China		32,179		32,179
Southeast Asia/Pacific		18,537		18,537
South Korea		29,261		29,261
Japan		16,019		16,019
EMEA		2,875		2,875
Hong Kong/Taiwan		6,634		6,634
Rhyz Investments
Manufacturing		78,875		78,875
Rhyz Other		12,603		12,603
Total	$	206,432	$	206,432

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 55
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

+ Details

Debt (Tables)

9 Months Ended

Sep. 30, 2022

Debt [Abstract]

Debt Facilities

The following table summarizes the Company’s debt facilities as of September 30, 2022 and December 31, 2021:

Facility or Arrangement	Original Principal Amount	Balance as of September 30, 2022 ⁽¹⁾⁽²⁾	Balance as of December 31, 2021⁽¹⁾⁽²⁾	Interest Rate	Repayment Terms
2018 Credit Agreement term loan facility	$400.0 million	—	$307.5 million	Variable 30 day: 2.80%	Principal amount was paid in full during June 2022.

2018 Credit Agreement revolving credit facility		—	$70.0 million	Variable 30 day: 2.72%	Principal amount was paid in full during June 2022 and credit line was closed.

Credit Agreement term loan facility	$400.0 million	$397.5 million	—	Variable 30 day: 4.88%	21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term.

Credit Agreement revolving credit facility		$30.0 million	—	Variable 30 day: 4.88%	Revolving line of credit expires June 14, 2027.

(1)	As of September 30, 2022 and December 31, 2021, the current portion of the Company’s debt (i.e., becoming due in the next 12 months) included $12.5 million and $37.5 million, respectively, of the balance of its term loan under the Credit Agreement and 2018 Credit Agreement.

(2)	The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.7 million and $1.2 million as of September 30, 2022 and December 31, 2021, respectively, related to the Credit Agreement and 2018 Credit Agreement, which are not reflected in this table.

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69E
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Leases (Tables)

9 Months Ended

Sep. 30, 2022

Leases [Abstract]

Components of Lease Expense

The components of lease expense were as follows (U.S. dollars in thousands):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2022		2021			2022		2021
Operating lease expense
Operating lease cost	$	9,479	$	12,193		$	30,179	$	37,408
Variable lease cost		1,572		1,121			4,223		4,145
Short-term lease cost		84		13			181		590
Sublease income		—		(1,352	)		—		(5,164	)
Finance lease expense
Amortization of right-of-use assets		530		594			1,632		1,811
Interest on lease liabilities		53		77			178		248
Total lease expense	$	11,718	$	12,646		$	36,393	$	39,038

Supplemental Cash Flow Information Related to Leases

Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands):

	Nine Months Ended September 30,
	2022		2021
Operating cash outflow from operating leases	$	28,880	$	40,072
Operating cash outflow from finance leases	$	170	$	250
Financing cash outflow from finance leases	$	1,401	$	1,409
Right-of-use assets obtained in exchange for operating lease obligations	$	28,785	$	19,120
Right-of-use assets obtained in exchange for finance lease obligations	$	203	$	59

Maturities of Lease Liabilities

Maturities of lease liabilities were as follows (U.S. dollars in thousands):

Year Ending December 31	Operating Leases		Finance Leases
2022	$	9,453	$	505
2023		26,680		1,884
2024		19,671		1,688
2025		13,775		1,209
2026		8,127		264
Thereafter		46,139		4
Total		123,845		5,554
Less: Finance charges		16,736		319
Total principal liability	$	107,109	$	5,235

Fair Value and Equity Investments (Tables)

9 Months Ended

Sep. 30, 2022

Fair Value and Equity Investments [Abstract]

Assets (Liabilities) Measured at Fair Value on a Recurring Basis

The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands):

	Fair Value at September 30, 2022
	Level 1		Level 2		Level 3			Total
Financial assets (liabilities):
Cash equivalents and current investments	$	68,552	$	—	$	—		$	68,552
Derivative financial instruments asset		—		21,168		—			21,168
Life insurance contracts		—		—		38,302			38,302
Contingent consideration		—		—		(8,372	)		(8,372	)
Total	$	68,552	$	21,168	$	29,930		$	119,650

	Fair Value at December 31, 2021
	Level 1		Level 2		Level 3			Total
Financial assets (liabilities):
Cash equivalents and current investments	$	66,477	$	—	$	—		$	66,477
Derivative financial instruments asset		—		6,590		—			6,590
Life insurance contracts		—		—		49,851			49,851
Contingent consideration		—		—		(10,341	)		(10,341	)
Total	$	66,477	$	6,590	$	39,510		$	112,577

Changes in Fair Value of Level 3 Life Insurance Contracts

The following table provides a summary of changes in fair value of the Company’s Level 3 life insurance contracts (U.S. dollars in thousands):

	2022			2021
Beginning balance at January 1	$	49,851		$	45,453
Actual return on plan assets		(11,549	)		3,172
Purchases and issuances		—			7,016
Sales and settlements		—			(7,016	)
Transfers into Level 3		—			—
Ending balance at September 30	$	38,302		$	48,625

Changes in Fair Value of Level 3 Contingent Consideration

The following table provides a summary of changes in fair value of the Company’s Level 3 contingent consideration (U.S. dollars in thousands):

	2022			2021
Beginning balance at January 1	$	(10,341	)	$	(3,125	)
Additions from acquisitions		—			(8,702	)
Changes in fair value of contingent consideration		1,969			(305	)
Ending balance at September 30	$	(8,372	)	$	(12,132	)

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

Derivatives and Hedging Activities (Tables)

9 Months Ended

Sep. 30, 2022

Derivatives and Hedging Activities [Abstract]

Fair Values of Derivative Instruments on the Balance Sheet

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet:

		Fair Values of Derivative Instruments
Derivatives in Cash flow Hedging Relationships:	Balance Sheet Location	September 30, 2022		December 31, 2021
Interest Rate Swap - Asset	Prepaid expenses and other	$	8,178	$	557
Interest Rate Swap - Asset	Other assets	$	12,990	$	6,033

Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income

The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income.

	Amount of Gain (Loss) Recognized in OCI on Derivatives
	Three Months Ended				Nine Months Ended
Derivatives in Cash flow	September 30,				September 30,
Hedging Relationships:	2022		2021		2022		2021
Interest Rate Swaps	$	5,832	$	32	$	15,903	$	3,133

		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income
		Three Months Ended					Nine Months Ended
Derivatives in Cash flow	Income Statement	September 30,					September 30,
Hedging Relationships:	Location	2022		2021			2022		2021
Interest Rate Swaps	Other income (expense), net	$	1,040	$	(45	)	$	1,323	$	(110	)

Segment Information (Tables)

9 Months Ended

Sep. 30, 2022

Segment Information [Abstract]

Revenue by Segment

	Three Months Ended September 30,				Nine Months Ended September 30,
(U.S. dollars in thousands)	2022		2021		2022		2021

Nu Skin
Americas	$	131,591	$	131,482	$	379,616	$	403,755
Mainland China		75,151		134,291		286,454		438,066
Southeast Asia/Pacific		83,502		79,081		267,805		246,338
South Korea		67,237		91,989		208,678		261,724
Japan		53,276		65,117		171,019		203,001
EMEA		45,099		55,839		148,938		215,134
Hong Kong/Taiwan		39,587		39,921		117,408		114,795
Nu Skin other		496		1,672		2,434		3,497
Total Nu Skin		495,939		599,392		1,582,352		1,886,310
Rhyz Investments
Manufacturing ⁽¹⁾		41,328		41,635		119,898		135,760
Rhyz other		538		125		1,069		163
Total Rhyz Investments		41,866		41,760		120,967		135,923
Total	$	537,805	$	641,152	$	1,703,319	$	2,022,233

(1)

Segment Contribution

	Three Months Ended September 30,						Nine Months Ended September 30,
(U.S. dollars in thousands)	2022			2021			2022			2021
Nu Skin
Americas	$	23,016		$	25,752		$	78,165		$	83,495
Mainland China		12,933			30,677			54,873			121,596
Southeast Asia/Pacific		20,719			19,020			68,492			59,881
South Korea		20,455			28,984			63,776			84,401
Japan		13,103			16,267			41,867			50,709
EMEA		3,379			6,693			13,377			29,270
Hong Kong/Taiwan		8,425			8,940			26,276			24,848
Nu Skin contribution		102,030			136,333			346,826			454,200
Rhyz Investments
Manufacturing		1,755			3,059			6,235			15,649
Rhyz other		(1,724	)		(659	)		(4,069	)		(1,178	)
Rhyz Investments contribution		31			2,400			2,166			14,471
Total segment contribution		102,061			138,733			348,992			468,671
Corporate and other		(122,345	)		(73,349	)		(265,604	)		(254,998	)
Operating income		(20,284	)		65,384			83,388			213,673
Other income (expense)		(8,680	)		2,781			(18,773	)		351
Income before provision for income taxes	$	(28,964	)	$	68,165		$	64,615		$	214,024

Depreciation and Amortization and Capital Expenditures

Depreciation and Amortization

	Three Months Ended September 30,				Nine Months Ended September 30,
(U.S. dollars in thousands)	2022		2021		2022		2021
Nu Skin
Americas	$	89	$	190	$	480	$	656
Mainland China		3,528		3,253		9,088		9,868
Southeast Asia/Pacific		382		359		1,144		1,096
South Korea		377		805		1,137		2,768
Japan		148		220		670		699
EMEA		125		281		599		850
Hong Kong/Taiwan		743		1,004		2,152		2,794
Total Nu Skin		5,392		6,112		15,270		18,731
Rhyz Investments
Manufacturing		3,161		3,069		9,773		8,644
Rhyz other		592		592		1,776		987
Total Rhyz Investments		3,753		3,661		11,549		9,631
Corporate and other		9,025		10,160		27,116		29,496
Total	$	18,170	$	19,933	$	53,935	$	57,858

Capital Expenditures

	Three Months Ended September 30,				Nine Months Ended September 30,
(U.S. dollars in thousands)	2022		2021		2022		2021
Nu Skin
Americas	$	23	$	95	$	152	$	294
Mainland China		2,946		3,237		9,066		15,170
Southeast Asia/Pacific		19		92		143		1,015
South Korea		35		—		613		508
Japan		16		3		200		94
EMEA		183		391		961		821
Hong Kong/Taiwan		587		110		1,386		222
Total Nu Skin		3,809		3,928		12,521		18,124
Rhyz Investments
Manufacturing		1,923		2,604		4,353		11,604
Rhyz other		—		—		—		—
Total Rhyz Investments		1,923		2,604		4,353		11,604
Corporate and other		19,723		7,003		28,400		20,656
Total	$	25,455	$	13,535	$	45,274	$	50,384

Restructuring (Tables)

9 Months Ended

Sep. 30, 2022

Restructuring [Abstract]

Restructuring Expense by Segment

Restructuring expense by segment

(U.S. dollars in thousands)	Three Months Ended September 30,2022

Nu Skin
Americas	$	1,723
Mainland China		11,484
Southeast Asia/Pacific		663
South Korea		54
Japan		—
EMEA		894
Hong Kong/Taiwan		747
Total Nu Skin		15,565
Rhyz Investments
Manufacturing		—
Rhyz other		—
Total Rhyz Investments		—
Corporate and other		14,559
Total	$	30,124

The Company (Details)	9 Months Ended
The Company (Details)	Sep. 30, 2022 Segment
The Company [Abstract]
Number of reportable segments	9
Number of geographic segments	7
Number of Rhyz Investments segments	2

Summary of Significant Accounting Policies, Reclassifications (Details) - Reclassification Adjustment [Member] - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
General and Administration Expenses [Member]
Reclassifications [Abstract]
Events and other miscellaneous selling costs	$ (4.6)	$ (9.5)
Selling Expenses [Member]
Reclassifications [Abstract]
Events and other miscellaneous selling costs	$ 4.6	$ 9.5

Summary of Significant Accounting Policies, Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventories [Abstract]
Raw materials	$ 141,823	$ 179,891
Finished goods	185,658	220,040
Total Inventory, net	$ 327,481	$ 399,931

Summary of Significant Accounting Policies, Revenue Recognition (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs	$ 17.7		$ 17.7		$ 22.0
Contract liabilities, increase (decrease) to revenue	$ 0.7	$ (0.7)	$ 4.3	$ (6.3)

Goodwill (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Goodwill [Abstract]
Goodwill	$ 206,432	$ 206,432
Americas [Member]
Goodwill [Abstract]
Goodwill	9,449	9,449
Mainland China [Member]
Goodwill [Abstract]
Goodwill	32,179	32,179
Southeast Asia/Pacific [Member]
Goodwill [Abstract]
Goodwill	18,537	18,537
South Korea [Member]
Goodwill [Abstract]
Goodwill	29,261	29,261
Japan [Member]
Goodwill [Abstract]
Goodwill	16,019	16,019
EMEA [Member]
Goodwill [Abstract]
Goodwill	2,875	2,875
Hong Kong/Taiwan [Member]
Goodwill [Abstract]
Goodwill	6,634	6,634
Manufacturing [Member]
Goodwill [Abstract]
Goodwill	78,875	78,875
Rhyz Other [Member]
Goodwill [Abstract]
Goodwill	$ 12,603	$ 12,603

Debt, 2018 Credit Agreement (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Apr. 18, 2018
2018 Credit Agreement [Member] \| Maximum [Member]
Debt [Abstract]
Consolidated leverage ratio	2.25
2018 Credit Agreement [Member] \| Minimum [Member]
Debt [Abstract]
Consolidated interest coverage ratio	3
2018 Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 400.0	$ 400.0
Term of loan	5 years
2018 Term Loan Facility [Member] \| First Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
2018 Term Loan Facility [Member] \| Second Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
2018 Term Loan Facility [Member] \| Third Year [Member]
Debt [Abstract]
Annual amortization percentage	7.50%
2018 Term Loan Facility [Member] \| Fourth Year [Member]
Debt [Abstract]
Annual amortization percentage	7.50%
2018 Term Loan Facility [Member] \| Fifth Year [Member]
Debt [Abstract]
Annual amortization percentage	10.00%
2018 Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity		$ 350.0
Term of loan	5 years

Debt, Credit Agreement (Details) - USD ($) $ in Millions	9 Months Ended
Debt, Credit Agreement (Details) - USD ($) $ in Millions	Sep. 30, 2022	Jun. 14, 2022
Credit Agreement [Member]
Debt [Abstract]
Percentage of capital stock of certain foreign subsidiaries pledged as collateral	65.00%
Credit Agreement [Member] \| Minimum [Member]
Debt [Abstract]
Commitment fee percentage payable on unused portion	0.175%
Consolidated interest coverage ratio	3
Credit Agreement [Member] \| Maximum [Member]
Debt [Abstract]
Commitment fee percentage payable on unused portion	0.30%
Consolidated leverage ratio	2.75
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 400.0	$ 400.0
Term of loan	5 years
Term Loan Facility [Member] \| First Year [Member]
Debt [Abstract]
Annual amortization percentage	2.50%
Term Loan Facility [Member] \| Second Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] \| Third Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] \| Fourth Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] \| Fifth Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity		$ 500.0
Term of loan	5 years

Debt, Debt Facilities (Details) - USD ($)
$ in Thousands

9 Months Ended

Sep. 30, 2022

Jun. 14, 2022

Dec. 31, 2021

Apr. 18, 2018

Debt [Abstract]

Term of variable rate

30 days

Current portion of long-term debt

$ 42,500

$ 107,500

2018 Credit Agreement [Member]

Debt [Abstract]

Unamortized debt issuance costs

1,200

2018 Credit Agreement Term Loan Facility [Member]

Debt [Abstract]

Original principal amount

400,000

$ 400,000

Balance

^[1],[2]

$ 0

307,500

Interest rate

Variable 30 day: 2.80%

Interest rate

2.80%

Term of variable rate

30 days

Repayment terms

Principal amount was paid in full during June 2022.

Term of loan

5 years

Current portion of long-term debt

37,500

2018 Credit Agreement Revolving Credit Facility [Member]

Debt [Abstract]

Balance

^[1],[2]

$ 0

70,000

Interest rate

Variable 30 day: 2.72%

Interest rate

2.72%

Term of variable rate

30 days

Repayment terms

Principal amount was paid in full during June 2022 and credit line was closed.

Term of loan

5 years

Credit Agreement [Member]

Debt [Abstract]

Unamortized debt issuance costs

$ 2,700

Credit Agreement Term Loan Facility [Member]

Debt [Abstract]

Original principal amount

400,000

$ 400,000

Balance

^[1],[2]

$ 397,500

Interest rate

Variable 30 day: 4.88%

Interest rate

4.88%

Term of variable rate

30 days

Repayment terms

21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term

Percentage of principal payable in installments

21.00%

Term of loan

5 years

Current portion of long-term debt

$ 12,500

Credit Agreement Revolving Credit Facility [Member]

Debt [Abstract]

Balance

^[1],[2]

$ 30,000

$ 0

Interest rate

Variable 30 day: 4.78%

Interest rate

4.88%

Term of variable rate

30 days

Repayment terms

Revolving line of credit expires June 14, 2027

Term of loan

5 years

[1]	As of September 30, 2022 and December 31, 2021, the current portion of the Company’s debt (i.e., becoming due in the next 12 months) included $12.5 million and $37.5 million, respectively, of the balance of its term loan under the Credit Agreement and 2018 Credit Agreement.
[2]	The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.7 million and $1.2 million as of September 30, 2022 and December 31, 2021, respectively, related to the Credit Agreement and 2018 Credit Agreement, which are not reflected in this table.

Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Weighted average remaining lease term for operating leases	8 years 4 months 24 days		8 years 4 months 24 days
Weighted average remaining lease term for finance leases	3 years		3 years
Weighted average discount rate for operating leases	3.50%		3.50%
Weighted average discount rate for finance leases	3.80%		3.80%
Operating Lease Expense [Abstract]
Operating lease cost	$ 9,479	$ 12,193	$ 30,179	$ 37,408
Variable lease cost	1,572	1,121	4,223	4,145
Short-term lease cost	84	13	181	590
Sublease income	0	(1,352)	0	(5,164)
Finance Lease Expense [Abstract]
Amortization of right-of-use assets	530	594	1,632	1,811
Interest on lease liabilities	53	77	178	248
Total lease expense	11,718	$ 12,646	36,393	39,038
Supplemental Cash Flow Information Related to Leases [Abstract]
Operating cash outflow from operating leases			28,880	40,072
Operating cash outflow from finance leases			170	250
Financing cash outflow from finance leases			1,401	1,409
Right-of-use assets obtained in exchange for operating lease obligations			28,785	19,120
Right-of-use assets obtained in exchange for finance lease obligations			203	$ 59
Maturities of Operating Lease Liabilities [Abstract]
2022	9,453		9,453
2023	26,680		26,680
2024	19,671		19,671
2025	13,775		13,775
2026	8,127		8,127
Thereafter	46,139		46,139
Total	123,845		123,845
Less: Finance charges	16,736		16,736
Total principal liability	107,109		107,109
Maturities of Financing Lease Liabilities [Abstract]
2022	505		505
2023	1,884		1,884
2024	1,688		1,688
2025	1,209		1,209
2026	264		264
Thereafter	4		4
Total	5,554		5,554
Less: Finance charges	319		319
Total principal liability	5,235		5,235
Additional lease liabilities not yet commenced	$ 100		$ 100

Capital Stock, Net Income per Share (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stock Options [Member]
Net Income per Share [Abstract]
Anti-dilutive shares excluded from calculation of diluted earnings per share (in shares)	0.5	0.1	0.1	0.1

Capital Stock, Dividends (Details) - USD ($) $ / shares in Units, $ in Thousands				1 Months Ended				9 Months Ended
	Sep. 07, 2022	Jun. 08, 2022	Mar. 09, 2022	Oct. 31, 2022	Aug. 31, 2022	May 31, 2022	Feb. 28, 2022	Sep. 30, 2022	Sep. 30, 2021
Dividends per Share [Abstract]
Payment of cash dividends								$ 57,988	$ 57,336
Dividend Declared 2022-Q1 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2022-02
Dividend payable per share (in dollars per share)							$ 0.385
Payment of cash dividends			$ 19,300
Dividend payable, date paid								Mar. 09, 2022
Dividend payable, date of record								Feb. 28, 2022
Dividend Declared 2022-Q2 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2022-05
Dividend payable per share (in dollars per share)						$ 0.385
Payment of cash dividends		$ 19,400
Dividend payable, date paid								Jun. 08, 2022
Dividend payable, date of record								May 27, 2022
Dividend Declared 2022-Q3 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2022-08
Dividend payable per share (in dollars per share)					$ 0.385
Payment of cash dividends	$ 19,300
Dividend payable, date paid								Sep. 07, 2022
Dividend payable, date of record								Aug. 26, 2022
Dividend Declared 2022-Q4 [Member] \| Subsequent Event [Member]
Dividends per Share [Abstract]
Dividend payable, date declared				2022-10
Dividend payable per share (in dollars per share)				$ 0.385
Dividend payable, date paid				Dec. 07, 2022
Dividend payable, date of record				Nov. 25, 2022

Capital Stock, Repurchase of Common Stock (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Repurchases of Common Stock [Abstract]
Class A common stock repurchased	$ 40,028	$ 10,005	$ 60,038	$ 70,415
Amount available for repurchases	$ 185,400		$ 185,400
Treasury Stock [Member]
Repurchases of Common Stock [Abstract]
Class A common stock repurchased (in shares)	1.0	0.2	1.4	1.4
Class A common stock repurchased	$ 40,028	$ 10,005	$ 60,038	$ 70,415

Fair Value and Equity Investments, Fair Value (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Fair Value and Equity Investments [Abstract]
Term of variable rate	30 days
Contingent Consideration [Member]
Changes in Fair Value of Level 3 Contingent Consideration [Roll Forward]
Beginning balance	$ (10,341)	$ (3,125)
Additions from acquisitions	0	(8,702)
Changes in fair value of contingent consideration	1,969	(305)
Ending balance	(8,372)	(12,132)
Fair Value on a Recurring Basis [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	68,552		$ 66,477
Derivative financial instruments asset	21,168		6,590
Life insurance contracts	38,302		49,851
Contingent consideration	(8,372)		(10,341)
Financial assets (liabilities)	119,650		112,577
Fair Value on a Recurring Basis [Member] \| Level 1 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	68,552		66,477
Derivative financial instruments asset	0		0
Life insurance contracts	0		0
Contingent consideration	0		0
Financial assets (liabilities)	68,552		66,477
Fair Value on a Recurring Basis [Member] \| Level 2 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0		0
Derivative financial instruments asset	21,168		6,590
Life insurance contracts	0		0
Contingent consideration	0		0
Financial assets (liabilities)	21,168		6,590
Fair Value on a Recurring Basis [Member] \| Level 3 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0		0
Derivative financial instruments asset	0		0
Life insurance contracts	38,302		49,851
Contingent consideration	(8,372)		(10,341)
Financial assets (liabilities)	29,930		$ 39,510
Life Insurance Contracts [Member]
Changes in Fair Value of Level 3 Marketable Securities [Roll Forward]
Beginning balance	49,851	45,453
Actual return on plan assets	(11,549)	3,172
Purchase and issuances	0	7,016
Sales and settlements	0	(7,016)
Transfers into Level 3	0	0
Ending balance	$ 38,302	$ 48,625

Fair Value and Equity Investments, Equity Investments (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Equity Securities without Readily Determinable Fair Value [Line Items]
Upward fair value adjustments on equity securities		$ 0	$ 18,077
Equity Securities [Member]
Equity Securities without Readily Determinable Fair Value [Line Items]
Carrying amount of equity securities without readily determinable fair values		$ 28,100		$ 28,100
Equity Securities [Member] \| Other Income (Expense), Net [Member]
Equity Securities without Readily Determinable Fair Value [Line Items]
Upward fair value adjustments on equity securities	$ 18,100

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Income Taxes [Abstract]
Provision (benefit) for income taxes	$ (3,574)	$ 18,436	$ 17,052	$ 57,527
Effective tax rate	12.30%	27.00%	26.40%	26.90%
Net deferred tax assets	$ 22,200		$ 22,200		$ 24,100
Undistributed earnings of non-U.S. subsidiaries					60,000
Incremental taxes if undistributed earnings on non-U.S. subsidiaries were repatriated					$ 6,000
Minimum [Member]
Income Taxes [Abstract]
Increase in unrecognized tax benefits within the next 12 months that is reasonably possible	1,000		$ 1,000
Maximum [Member]
Income Taxes [Abstract]
Statute of limitations related to income tax examinations			10 years
Income Taxes [Abstract]
Increase in unrecognized tax benefits within the next 12 months that is reasonably possible	$ 2,000		$ 2,000

Derivatives and Hedging Activities, Fair Value of Derivative Instruments on the Balance Sheet (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($) Derivatives	Dec. 31, 2021 USD ($) Derivatives
Derivatives and Hedging Activities [Abstract]
Loss to be reclassified to interest expense during next twelve months	$ 8,200
Number of outstanding derivatives held \| Derivatives	4	4
Notional amount	$ 200,000	$ 200,000
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Prepaid Expenses and Other [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	8,178	557
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Other Assets [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	$ 12,990	$ 6,033

Derivatives and Hedging Activities, Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Details) - Interest Rate Swaps [Member] - Designated as Hedging Instrument [Member] - Cash Flow Hedges [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income (Expense), Net [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	$ 1,040	$ (45)	$ 1,323	$ (110)
Other Comprehensive Income [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) recognized in OCI	$ 5,832	$ 32	$ 15,903	$ 3,133

Segment Information, Revenue by Segment (Details)
$ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2022

USD ($)

Sep. 30, 2021

USD ($)

Sep. 30, 2022

USD ($)

Segment

Sep. 30, 2021

USD ($)

Segment Information [Abstract]

Number of reportable segments | Segment

Number of geographic segments | Segment

Number of Rhyz Investments segments | Segment

Revenue by Segment [Abstract]

Revenue

$ 537,805

$ 641,152

$ 1,703,319

$ 2,022,233

Other [Member]

Revenue by Segment [Abstract]

Revenue

496

1,672

2,434

3,497

Operating Segment [Member] | Nu Skin [Member]

Revenue by Segment [Abstract]

Revenue

495,939

599,392

1,582,352

1,886,310

Operating Segment [Member] | Americas [Member]

Revenue by Segment [Abstract]

Revenue

131,591

131,482

379,616

403,755

Operating Segment [Member] | Mainland China [Member]

Revenue by Segment [Abstract]

Revenue

75,151

134,291

286,454

438,066

Operating Segment [Member] | Southeast Asia/Pacific [Member]

Revenue by Segment [Abstract]

Revenue

83,502

79,081

267,805

246,338

Operating Segment [Member] | South Korea [Member]

Revenue by Segment [Abstract]

Revenue

67,237

91,989

208,678

261,724

Operating Segment [Member] | Japan [Member]

Revenue by Segment [Abstract]

Revenue

53,276

65,117

171,019

203,001

Operating Segment [Member] | EMEA [Member]

Revenue by Segment [Abstract]

Revenue

45,099

55,839

148,938

215,134

Operating Segment [Member] | Hong Kong/Taiwan [Member]

Revenue by Segment [Abstract]

Revenue

39,587

39,921

117,408

114,795

Operating Segment [Member] | Rhyz Investments [Member]

Revenue by Segment [Abstract]

Revenue

41,866

41,760

120,967

135,923

Operating Segment [Member] | Manufacturing [Member]

Revenue by Segment [Abstract]

Revenue

^[1]

41,328

41,635

119,898

135,760

Operating Segment [Member] | Rhyz Other [Member]

Revenue by Segment [Abstract]

Revenue

538

125

1,069

163

Intersegment [Member] | Manufacturing [Member]

Revenue by Segment [Abstract]

Revenue

$ 17,500

$ 27,400

$ 48,900

$ 68,000

[1]

Segment Information, Segment Contribution (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Contribution [Abstract]
Operating income	$ (20,284)	$ 65,384	$ 83,388	$ 213,673
Other income (expense)	(8,680)	2,781	(18,773)	351
Income before provision for income taxes	(28,964)	68,165	64,615	214,024
Operating Segment [Member]
Segment Contribution [Abstract]
Operating income	102,061	138,733	348,992	468,671
Operating Segment [Member] \| Nu Skin [Member]
Segment Contribution [Abstract]
Operating income	102,030	136,333	346,826	454,200
Operating Segment [Member] \| Americas [Member]
Segment Contribution [Abstract]
Operating income	23,016	25,752	78,165	83,495
Operating Segment [Member] \| Mainland China [Member]
Segment Contribution [Abstract]
Operating income	12,933	30,677	54,873	121,596
Operating Segment [Member] \| Southeast Asia/Pacific [Member]
Segment Contribution [Abstract]
Operating income	20,719	19,020	68,492	59,881
Operating Segment [Member] \| South Korea [Member]
Segment Contribution [Abstract]
Operating income	20,455	28,984	63,776	84,401
Operating Segment [Member] \| Japan [Member]
Segment Contribution [Abstract]
Operating income	13,103	16,267	41,867	50,709
Operating Segment [Member] \| EMEA [Member]
Segment Contribution [Abstract]
Operating income	3,379	6,693	13,377	29,270
Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Segment Contribution [Abstract]
Operating income	8,425	8,940	26,276	24,848
Operating Segment [Member] \| Rhyz Investments [Member]
Segment Contribution [Abstract]
Operating income	31	2,400	2,166	14,471
Operating Segment [Member] \| Manufacturing [Member]
Segment Contribution [Abstract]
Operating income	1,755	3,059	6,235	15,649
Operating Segment [Member] \| Rhyz Other [Member]
Segment Contribution [Abstract]
Operating income	(1,724)	(659)	(4,069)	(1,178)
Corporate and Other [Member]
Segment Contribution [Abstract]
Operating income	$ (122,345)	$ (73,349)	$ (265,604)	$ (254,998)

Segment Information, Depreciation and Amortization and Capital Expenditures (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Summarized Financial Information [Abstract]
Depreciation and amortization	$ 18,170	$ 19,933	$ 53,935	$ 57,858
Capital expenditures	25,455	13,535	45,274	50,384
Operating Segments [Member] \| Nu Skin [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	5,392	6,112	15,270	18,731
Capital expenditures	3,809	3,928	12,521	18,124
Operating Segments [Member] \| Americas [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	89	190	480	656
Capital expenditures	23	95	152	294
Operating Segments [Member] \| Mainland China [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,528	3,253	9,088	9,868
Capital expenditures	2,946	3,237	9,066	15,170
Operating Segments [Member] \| Southeast Asia/Pacific [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	382	359	1,144	1,096
Capital expenditures	19	92	143	1,015
Operating Segments [Member] \| South Korea [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	377	805	1,137	2,768
Capital expenditures	35	0	613	508
Operating Segments [Member] \| Japan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	148	220	670	699
Capital expenditures	16	3	200	94
Operating Segments [Member] \| EMEA [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	125	281	599	850
Capital expenditures	183	391	961	821
Operating Segments [Member] \| Hong Kong/Taiwan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	743	1,004	2,152	2,794
Capital expenditures	587	110	1,386	222
Operating Segments [Member] \| Rhyz Investments [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,753	3,661	11,549	9,631
Capital expenditures	1,923	2,604	4,353	11,604
Operating Segments [Member] \| Manufacturing [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,161	3,069	9,773	8,644
Capital expenditures	1,923	2,604	4,353	11,604
Operating Segments [Member] \| Rhyz Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	592	592	1,776	987
Capital expenditures	0	0	0	0
Corporate and Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	9,025	10,160	27,116	29,496
Capital expenditures	$ 19,723	$ 7,003	$ 28,400	$ 20,656

Acquisitions (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
Acquisitions (Details) - USD ($) $ in Thousands	Apr. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Acquisitions [Abstract]
Purchase price, net of cash acquired		$ 0	$ 18,963
Fair Value of Assets Acquired [Abstract]
Goodwill		$ 206,432		$ 206,432
Mavely [Member]
Acquisitions [Abstract]
Percentage interest acquired	100.00%
Purchase price, net of cash acquired	$ 16,800
Cash acquired	400
Accrued liability	900
Incremental contingent consideration	24,000
Contingent consideration	8,700
Gross purchase price	29,400
Fair Value of Assets Acquired [Abstract]
Intangible assets	16,400
Cash	400
Accounts receivable	100
Deferred tax liability	3,500
Goodwill	12,600
Mavely [Member] \| Customer Relationships [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	2,000
Useful life		4 years
Mavely [Member] \| Technology [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	11,300
Useful life		8 years
Mavely [Member] \| Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	2,800
Mavely [Member] \| Tradenames [Member]
Fair Value of Assets Acquired [Abstract]
Useful life		8 years
Mavely [Member] \| Other Intangibles [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	$ 300
Useful life		3 years

Restructuring, Exit Grow Tech Segment (Details) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restructuring [Abstract]
Non-cash impairment charges	$ 30,124				$ 0	$ 30,124	$ 0
Cash payments	300	$ 8,000	$ 11,600
Ending restructuring accrual	$ 0	$ 300	$ 8,300			$ 0
Exit Grow Tech Segment [Member]
Restructuring [Abstract]
Non-cash impairment charges				$ 38,500
Impairment of goodwill				9,200
Impairment of intangible assets				9,000
Impairment of fixed assets				13,700
Inventory write-off				6,600
Cash charges associated with restructuring				20,000
Employee severance				6,500
Other related restructuring charges				13,500
Exit Grow Tech Segment [Member] \| Accrued Expenses [Member]
Restructuring [Abstract]
Liability related to cash charges				$ 20,000

Restructuring, Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restructuring [Abstract]
Cash payments	$ 300	$ 8,000	$ 11,600
Ending restructuring accrual	0	$ 300	$ 8,300		$ 0
Restructuring expense	30,124			$ 0	30,124	$ 0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member]
Restructuring [Abstract]
Severance charges	17,200
Lease termination cost	2,100
Other associated restructuring charges	900
Impairment of fixed assets	8,200
Impairment of intangible assets	1,700
Cash payments	7,900
Ending restructuring accrual	12,300				12,300
Restructuring expense	30,124
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Minimum [Member]
Restructuring [Abstract]
Estimated restructuring costs	35,000				35,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Maximum [Member]
Restructuring [Abstract]
Estimated restructuring costs	45,000				45,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Nu Skin [Member]
Restructuring [Abstract]
Restructuring expense	15,565
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Americas [Member]
Restructuring [Abstract]
Restructuring expense	1,723
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Mainland China [Member]
Restructuring [Abstract]
Restructuring expense	11,484
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Southeast Asia/Pacific [Member]
Restructuring [Abstract]
Restructuring expense	663
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| South Korea [Member]
Restructuring [Abstract]
Restructuring expense	54
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Japan [Member]
Restructuring [Abstract]
Restructuring expense	0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| EMEA [Member]
Restructuring [Abstract]
Restructuring expense	894
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Restructuring [Abstract]
Restructuring expense	747
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Rhyz Investments [Member]
Restructuring [Abstract]
Restructuring expense	0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Manufacturing [Member]
Restructuring [Abstract]
Restructuring expense	0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Rhyz Other [Member]
Restructuring [Abstract]
Restructuring expense	0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Corporate and Other [Member]
Restructuring [Abstract]
Restructuring expense	14,559
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Severance and Lease Termination [Member] \| Minimum [Member]
Restructuring [Abstract]
Estimated restructuring costs	30,000				30,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Severance and Lease Termination [Member] \| Maximum [Member]
Restructuring [Abstract]
Estimated restructuring costs	35,000				35,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Impairment of Fixed Assets and Other Intangibles Related to Footprint Optimization [Member]
Restructuring [Abstract]
Estimated restructuring costs	$ 9,900				$ 9,900